Spoken Alpha
APVO
Aptevo Therapeutics Inc.
Overview
Aptevo Therapeutics Inc is a Healthcare company operating in Biotechnology with a $3.1M market cap.
Most recent reported earnings: Q3 FY2026 (Nov 4, 2026).
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Transcripts
Recent earnings calls
No earnings calls indexed for APVO yet
We index calls for roughly 3,000 US-listed companies. If you'd like us to add APVO, reply to your welcome email and we'll prioritize it.
History
Earnings history
- Q3 FY20262026-11-04EPS— vs $-4.46—Rev— vs ——EODHD
- Q2 FY20262026-08-13EPS$-5.31 vs $-6.02+11.8%Rev$0 vs ——EODHD
- Q1 FY20262026-05-12EPS$-6.41 vs $-5.60-14.5%Rev$0 vs ——EODHD
- Q4 FY20252026-03-25EPS$-5.91 vs $-8.09+26.9%Rev$-220.0K vs ——EODHD
- Q3 FY20252025-11-05EPS$-40.14 vs $-37.62-6.7%Rev$0 vs ——EODHD
- Q2 FY20252025-08-10EPS$-151.20 vs $-1497.60+89.9%Rev$0 vs ——EODHD
- Q1 FY20252025-05-14EPS$-4.39 vs $-4.21-4.3%Rev$0 vs ——EODHD
- Q4 FY20242025-02-13EPS$-3218.40 vs $-2790.00-15.3%Rev$0 vs ——EODHD
- Q3 FY20242024-11-06EPS$-6393.60 vs $-7592.40+15.8%Rev$0 vs ——EODHD
- Q2 FY20242024-08-07EPS$-22244.40 vs $-25707.61+13.5%Rev$0 vs ——EODHD
- Q1 FY20242024-05-07EPS$-132534.03 vs $-171095.43+22.5%Rev$0 vs ——EODHD
- Q4 FY20232024-03-04EPS$-6.16 vs $-18.04+65.8%Rev$902.0K vs ——EODHD
- Q3 FY20232023-11-13EPS$-293039.71 vs $-439559.56+33.3%Rev$0 vs ——EODHD
- Q2 FY20232023-08-09EPS$-720877.68 vs $-656408.94-9.8%Rev$0 vs ——EODHD
- Q1 FY20232023-05-10EPS$-652892.47 vs $-638826.56-2.2%Rev$0 vs ——EODHD
- Q4 FY20222023-03-29EPS$-0.95 vs $-1.53+37.9%Rev$-3.1M vs ——EODHD
- Q3 FY20222022-11-09EPS$-899045.82 vs $-890840.71-0.9%Rev$0 vs ——EODHD
- Q2 FY20222022-08-10EPS$-1000000.00 vs $-779485.62-28.3%Rev$0 vs ——EODHD
- Q1 FY20222022-05-11EPS$-931866.27 vs $-673991.33-38.3%Rev$3.1M vs ——EODHD
- Q4 FY20212022-03-23EPS$-1.27 vs $-1.29+1.6%Rev$3.7M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | — | $-4.46 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-13 | $-5.31 | $-6.02 | +11.8% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-12 | $-6.41 | $-5.60 | -14.5% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-03-25 | $-5.91 | $-8.09 | +26.9% | $-220.0K | — | — | EODHD |
| Q3 FY2025 | 2025-11-05 | $-40.14 | $-37.62 | -6.7% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-10 | $-151.20 | $-1497.60 | +89.9% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-14 | $-4.39 | $-4.21 | -4.3% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-02-13 | $-3218.40 | $-2790.00 | -15.3% | $0 | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $-6393.60 | $-7592.40 | +15.8% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $-22244.40 | $-25707.61 | +13.5% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-05-07 | $-132534.03 | $-171095.43 | +22.5% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-03-04 | $-6.16 | $-18.04 | +65.8% | $902.0K | — | — | EODHD |
| Q3 FY2023 | 2023-11-13 | $-293039.71 | $-439559.56 | +33.3% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $-720877.68 | $-656408.94 | -9.8% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-652892.47 | $-638826.56 | -2.2% | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-03-29 | $-0.95 | $-1.53 | +37.9% | $-3.1M | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-899045.82 | $-890840.71 | -0.9% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-10 | $-1000000.00 | $-779485.62 | -28.3% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-11 | $-931866.27 | $-673991.33 | -38.3% | $3.1M | — | — | EODHD |
| Q4 FY2021 | 2022-03-23 | $-1.27 | $-1.29 | +1.6% | $3.7M | — | — | EODHD |
Source: EODHD. APVO reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Marvin L WhiteCEO10 yr 2 mono recorded callsCurrent
- Daphne TaylorCFO3 yr 6 mono recorded callsCurrent
- Jeffrey G LamotheCOO3 yr 6 mono recorded callsCurrent
- Mary Jo JanatpourSVP, CSO4 mono recorded callsCurrent
- Dirk HuebnerSVP, CMO1 yr 2 mono recorded callsCurrent
- Soyoung KwonSVP, GC, BD & Corp Affairs3 yr 6 mono recorded callsCurrent
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for APVO.
$ curl https://api.spokenalpha.com/v1/companies/APVOFAQ
Frequently asked about APVO
Where can I find Aptevo Therapeutics Inc.'s (APVO) earnings call transcripts?
Spoken Alpha indexes APVO's earnings call transcripts at https://spokenalpha.com/companies/APVO. Each call links to attributed speakers and parsed analyst Q&A.
What sector is APVO in?
Aptevo Therapeutics Inc. (APVO) operates in the Healthcare sector (Biotechnology industry).